Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.30 Thursday, 9th May 2024 GERN stock ended at $3.88. This is 1.84% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.16% from a day low at $3.80 to a day high of $3.92.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
Oct 20, 2016 $2.07 $2.13 $2.06 $2.09 1 214 300
Oct 19, 2016 $2.15 $2.15 $2.06 $2.08 1 169 300
Oct 18, 2016 $2.13 $2.16 $2.05 $2.14 1 540 500
Oct 17, 2016 $2.21 $2.23 $2.02 $2.08 2 066 500
Oct 14, 2016 $2.25 $2.26 $2.19 $2.19 1 283 400
Oct 13, 2016 $2.19 $2.27 $2.19 $2.21 1 422 100
Oct 12, 2016 $2.38 $2.40 $2.20 $2.21 1 880 900
Oct 11, 2016 $2.40 $2.45 $2.32 $2.36 1 369 700
Oct 10, 2016 $2.29 $2.41 $2.28 $2.40 1 257 100
Oct 07, 2016 $2.40 $2.41 $2.28 $2.29 1 431 700
Oct 06, 2016 $2.26 $2.43 $2.26 $2.37 2 511 900
Oct 05, 2016 $2.28 $2.32 $2.26 $2.29 1 068 800
Oct 04, 2016 $2.34 $2.34 $2.26 $2.27 1 292 300
Oct 03, 2016 $2.30 $2.32 $2.21 $2.29 1 328 500
Sep 30, 2016 $2.22 $2.30 $2.18 $2.26 1 311 000
Sep 29, 2016 $2.29 $2.29 $2.19 $2.20 1 373 100
Sep 28, 2016 $2.30 $2.35 $2.25 $2.27 1 177 100
Sep 27, 2016 $2.23 $2.28 $2.20 $2.26 1 338 100
Sep 26, 2016 $2.20 $2.23 $2.17 $2.21 1 499 800
Sep 23, 2016 $2.26 $2.26 $2.18 $2.20 1 985 900
Sep 22, 2016 $2.30 $2.31 $2.12 $2.22 2 708 300
Sep 21, 2016 $2.09 $2.26 $2.08 $2.25 3 616 800
Sep 20, 2016 $2.02 $2.12 $2.01 $2.05 2 887 900
Sep 19, 2016 $2.00 $2.05 $1.94 $2.00 3 473 800
Sep 16, 2016 $1.97 $1.99 $1.84 $1.88 4 199 300
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT